Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Tumid erythematosus lupus is considered a rare type of chronic cutaneous lupus erythematosus. Cutaneous lupus erythematosus (CLE) can be divided into acute cutaneous lupus, subacute cutaneous lupus, and chronic cutaneous lupus. Tumid erythematosus lupus is characterized by smooth, non-scarring, pink- to violet-colored pimples (papules)on the skin without any other apparent skin changes, such as scarring. Patients with tumid lupus erythematosus usually do not have other symptoms of systemic lupus erythematosus or other types of cutaneous lupus erythematosus. The papules appear on sun-exposed areas of the face, upper back, V area of the neck, trunk, and arms, and more rarely on thighs and legs. They usually affect equally both sides of the body, but may affect only one side. Normally, the papules clear without leaving scars. The treatment is very effective in most cases, and may include sun protection, anti-malarials drugs, local corticosteroids, topical tacrolimus and light therapy.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for lupus erythematosus tumidus.
17 publications have been identified in PubMed for lupus erythematosus tumidus. Research spans Case Report / Case Series (65%), Review / Meta-Analysis (18%), and Clinical Trial Publication (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 11 | 65% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 1:47 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
3 |
18% |
Clinical study results | 3 | 18% |
Koritala T (2026). [PMID: 29494121](https://pubmed.ncbi.nlm.nih.gov/29494121/). *Unknown Journal*. [Review / Meta-Analysis]
Gunduz H (2026). [PMID: 41808675](https://pubmed.ncbi.nlm.nih.gov/41808675/). *JAAD case reports*. [Case Report / Case Series]
Aung T (2026). [PMID: 41939593](https://pubmed.ncbi.nlm.nih.gov/41939593/). *Cureus*. [Case Report / Case Series]
Sukumaran S (2026). [PMID: 29630197](https://pubmed.ncbi.nlm.nih.gov/29630197/). *Unknown Journal*. [Review / Meta-Analysis]
Mizes A (2025). [PMID: 40104273](https://pubmed.ncbi.nlm.nih.gov/40104273/). *JAAD case reports*. [Case Report / Case Series]
Petelinsek S (2025). [PMID: 41466926](https://pubmed.ncbi.nlm.nih.gov/41466926/). *Cureus*. [Review / Meta-Analysis]
Olivares-Guerrero M (2025). [PMID: 40342196](https://pubmed.ncbi.nlm.nih.gov/40342196/). *Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG*. [Case Report / Case Series]
La Rotta-Higuera E (2025). [PMID: 39947587](https://pubmed.ncbi.nlm.nih.gov/39947587/). *Actas dermo-sifiliograficas*. [Clinical Trial Publication]
Kaufman L (2025). [PMID: 39996407](https://pubmed.ncbi.nlm.nih.gov/39996407/). *International journal of dermatology*. [Case Report / Case Series]
Alharbe A (2025). [PMID: 39817268](https://pubmed.ncbi.nlm.nih.gov/39817268/). *Cureus*. [Case Report / Case Series]
AI-curated news mentioning lupus erythematosus tumidus
Updated Sep 3, 2026
A recent study highlights the diagnostic challenges associated with atypical facial and scalp lupus erythematosus tumidus, emphasizing long-term misdiagnosis and conflicting histopathological findings. This research underscores the need for improved diagnostic criteria in rare dermatological conditions.